Page last updated: 2024-10-30

leflunomide and Gram-Negative Bacterial Infections

leflunomide has been researched along with Gram-Negative Bacterial Infections in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Gram-Negative Bacterial Infections: Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smeets, JG1
Löwe, SH1
Veraart, JC1

Other Studies

1 other study available for leflunomide and Gram-Negative Bacterial Infections

ArticleYear
Cutaneous infections with Stenotrophomonas maltophilia in patients using immunosuppressive medication.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2007, Volume: 21, Issue:9

    Topics: Adjuvants, Immunologic; Adult; Aged; Arthritis, Rheumatoid; Cross Infection; Cyclophosphamide; Femal

2007